Breathe Well Live Well
Monthly Prescribing Reference |
Don't Rely on OTC Homeopathic Asthma Products, Warns FDA
Monthly Prescribing Reference Many of these products include indications ranging from treatment of acute asthma symptoms to temporary relief of minor asthma symptoms. If it is not properly treated and managed, patients may experience wheezing, shortness of breath, cough, and be at … Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement … |
View full post on asthma – Google News
Monthly Prescribing Reference |
Cautious Use of Prenatal Antibiotics Advised
Monthly Prescribing Reference Of the 103 children born to mothers who took antibiotics during pregnancy, 22% were diagnosed with asthma by age 3 compared with 11% of children born to mothers who did not take antibiotics during pregnancy. Analyses on the timing of prenatal … Study: Pregnant women need to avoid antibiotics to prevent asthma … Public Release: 3-Mar-2015 Pregnant women with asthma need to curb urge to … Pregnant Women with Asthma Need to Curb Urge to ask for Antibiotics |
View full post on asthma – Google News
HCPLive |
Work-Related Asthma Underdiagnosed, Under-Recognized
Monthly Prescribing Reference (HealthDay News) — Only 15 percent of working adults with asthma discuss with their doctor how their jobs might affect their breathing, even though nearly half have asthma that is possibly work-related, according to a study published in the February … Why Patients Won't Talk to Their Docs About Work-Related Asthma Demographics, not location, explain high inner-city asthma rates Can we talk? Patients may avoid topic of work-related asthma for fear of … |
View full post on asthma – Google News
Monthly Prescribing Reference |
New Inhalers for Asthma, COPD Launched
Monthly Prescribing Reference GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation powder). Arnuity Ellipta is an inhaled corticosteroid indicated for the maintenance treatment of asthma … GSK Expands Portfolio of Asthma/COPD Medicines in U.S. GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
|
Is SLIT-Tablet Tx Safe for Asthma Patients with Allergic Rhinitis?
Monthly Prescribing Reference All subjects had a confirmed diagnosis of grass-pollen-induced AR/C with or without controlled asthma and a history of medication use to treat symptoms of AR/C during the previous pollen season. A total of 3,314 adult patients and 881 pediatric … |
View full post on asthma – Google News
|
Does Umeclidinium Monotherapy Help Asthma Patients Without ICS?
Monthly Prescribing Reference However, no studies have assessed a long-acting muscarinic antagonist in the absence of inhaled corticosteroids (ICS) for asthma patients. A new study in Respiratory Medicine reports on a double-blind, three-period crossover study of 350 asthma … |
View full post on asthma – Google News
Monthly Prescribing Reference |
Overweight Children More Likely to Report Worse Asthma Control
Monthly Prescribing Reference Children with early-onset asthma who are overweight or obese may mistake exertional dyspnea and esophageal reflux for loss of asthma control, causing them to use more rescue medication. In a study published in the Journal of Allergy and Clinical … Overweight kids misinterpret asthma symptoms, potentially overuse medication Obese Asthmatics Overuse Rescue Medications Seven recent developments involving food allergy |
View full post on asthma – Google News
|
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events
Monthly Prescribing Reference The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with … Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of … |
View full post on asthma – Google News
|
Asthma Risk Up with Fear of Job Loss, Study Suggests
Monthly Prescribing Reference Perceived job insecurity during an economic downturn may increase the risk of newly onset asthma, according to a new study published in the Journal of Epidemiology & Community Health. Using prospective data from the German Socio-Economic Panel for … |
View full post on asthma – Google News
|
Positive Results for Reslizumab in Asthma Trials
Monthly Prescribing Reference Teva announced positive results from its Phase 3 studies of reslizumab in patients with uncontrolled moderate to severe asthma with elevated eosinophils, treated with standard of care therapies. Reslizumab is an investigational humanized monoclonal … Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 Trials |
View full post on asthma – Google News